Find Academic Supervisors

Erich C. DierdorffView profile

Professor

• Organizational Behavior
• Human Resource Management
• Data Science
• +4 more

Erich C. Dierdorff serves as a Professor and William E. Hay Leadership Fellow in the Department of Management & Entrepreneurship at DePaul University's Driehaus College of Business. An award-winning instructor across executive, graduate, and undergraduate business programs, he specializes in organizational behavior, human resource management, and data science applications. His research examines individual/team learning effectiveness, work analysis, and leadership practices with significant industry impact. Education: PhD in Industrial-Organizational Psychology, North Carolina State University MS in Industrial-Organizational Psychology, North Carolina State University BS in Psychology (Minor: Sociology), University of Florida Research Focus: Professor Dierdorff investigates job crafting dynamics, team resilience under stress, and data-driven work design. His work integrates multilevel analysis of psychological collectivism in teams, goal orientation variability, and reciprocity mechanisms in organizational citizenship behavior, often applying data science to human capital problems. Publication Trends: Recent articles (2017-2025) reveal consistent emphasis on team training evaluation, job crafting motives, and work design consequences. He frequently publishes in top-tier journals like Journal of Applied Psychology and Academy of Management Journal, with growing focus on contextual moderators and longitudinal team performance patterns. Scientific Awards: William E. Hay Leadership Fellow Advising and Grants: While specific students or grants aren't listed, his industry partnerships with General Electric, Amazon Web Services, Siemens, and the U.S. Department of Labor indicate substantial contract research funding. He contributes evidence-based interventions in leadership development, competency modeling, and selection system design across corporate, sports, and military sectors. Labs and Teams: Professor Dierdorff developed TeamMATE® for team training evaluation (2016) and works with cross-functional industry teams. His research on O*NET tools and the greening of occupations involves U.S. Department of Labor collaborations, focusing on real-world human capital analytics.

Hélène GirouardView profile

Professor

• Neurovascular Coupling
• Arterial Stiffness
• Hypertension
• +5 more

Hélène Girouard is a full professor in the Department of Pharmacology and Physiology at the Faculty of Medicine, Université de Montréal, and directs the Cerebrovascular Pharmacology Laboratory at CRIUGM. Her research explores neurovascular coupling mechanisms, vascular contributions to cognitive decline, and sex/gender differences in neurodegenerative diseases. PhD in Cardiovascular Physiology (Université de Montréal, 2002) Postdoctoral Training: Cornell University (2003-2006), University of Vermont (2006-2008) Research Focus: Investigates how arterial stiffness , hypertension , and neuroinflammation disrupt neurovascular coupling , accelerating cognitive decline and Alzheimer's pathology . Special emphasis on sex differences and menopausal transitions in vascular brain health. Key Techniques: Multi-photon microscopy, laser Doppler flowmetry, MRI biomarkers, and in vivo / in vitro cerebrovascular pharmacology. Scientific Awards: 2002: Top 5% PhD Theses, Université de Montréal 2004: CIHR Recognition Award 2012: Jacques de Champlain Prize (Heart & Stroke Foundation) 2015: Fellow of the American Heart Association Training & Grants: Over 20 years of continuous funding from CIHR , FRQS , FMCC , NSERC , and Brain Canada . Supervises students in neurovascular imaging , vascular dementia , and sex-specific brain aging .

• Dementia
• Neurodegeneration
• Cognitive Neuroscience
• +6 more

Professor James B. Rowe is a distinguished cognitive neurologist at the University of Cambridge, holding positions at the MRC Cognition and Brain Sciences Unit and Cambridge Neuroscience. His research program focuses on dementia and neurodegeneration, with four integrated pillars: defining cognitive processes affected by dementia, determining mechanisms of individual differences, predicting brain function trajectories across the lifespan, and developing new drugs to protect or restore brain function. University of Cambridge, School of Clinical Medicine MRC Cognition and Brain Sciences Unit Cambridge Neuroscience Rowe's research spans multiple neurodegenerative conditions including Alzheimer's disease, frontotemporal dementia, Parkinson's disease, and progressive supranuclear palsy. He utilizes advanced neuroimaging techniques (MEG, EEG, fMRI, DWI, PET) alongside cognitive modeling, genetics, and neuropathology to understand disease mechanisms. His work emphasizes precision biomarkers for experimental medicine studies in precisely characterized clinical populations. Analysis of his recent publications (2023-2025) reveals strong focus on synaptic loss, neuroinflammation, and noradrenergic dysfunction across neurodegenerative diseases. His team has pioneered the use of [11C]UCB-J PET to measure synaptic density in vivo, demonstrating its relationship to clinical severity in frontotemporal dementia. There's also significant work on blood-based biomarkers of inflammation and their relationship to central pathology and survival outcomes. Fellow of the Academy of Medical Sciences (FMedSci) Principal investigator for multiple major studies including CamCAN, GENFI, PROSPECT, ICICLE-PD, and PiPPIN Rowe leads an extensive research program with collaborations across Europe and beyond, conducting both observational and interventional studies. His team has established robust methods for harmonizing cognitive data across aging and dementia cohorts, enabling large-scale analyses. Current work focuses on developing the Cambridge Questionnaire for Apathy and Impulsivity Traits (CamQUAIT) and investigating noradrenergic contributions to cognitive processes in Parkinson's disease through pharmacological interventions. His laboratory integrates multiple methodologies including magnetoencephalography, PET imaging, cognitive testing, and blood biomarker analysis to understand the neural basis of cognitive changes in neurodegenerative diseases. Recent work has established important links between locus coeruleus integrity, noradrenergic function, and cognitive symptoms in parkinsonian disorders.

• Cellular Neurophysiology
• Glial Physiology
• Neurodegenerative Diseases
• +6 more

Professor Alexej Verkhratsky is a leading scholar at the University of Manchester , holding the Professor of Neurophysiology position in the Division of Neuroscience. With over 400 peer-reviewed publications and an H-index of 86, he is a globally recognized expert in glial physiology and neurodegenerative diseases. Member of Academia Europaea (Vice-President, Life Sciences) Elected to German National Academy of Sciences Leopoldina (2013) Highly Cited Researcher (2023) His research focuses on neuroglial communication , pioneering discoveries in calcium and sodium signaling in astrocytes and microglia. Key contributions include: Foundational work on glial excitability via Ca²⁺/Na⁺ dynamics Development of the astroglial cradle concept for synaptic regulation Identification of astroglial atrophy as an early marker in Alzheimer's disease Characterization of glial paralysis in neurodegeneration Caffeine-induced Ca²⁺ release mechanisms Role of P2X receptors in gliotransmission Recent publications (2025-2026) highlight his work on: Mitochondrial responses in Alzheimer's and tauopathies Glial regulation of cerebrospinal fluid dynamics Neurodegenerative mechanisms in white matter pathology Scientific Awards include: Copernicus Gold Medal (2017) Dana Alliance for Brain Initiatives (2012) Multiple academy memberships (Slovenian Academy of Sciences, Real Academia Nacional de Farmacia, Poland National Academy of Sciences) As Editor-in-Chief of Cell Calcium and Deputy Editor of Cell Death and Disease , he shapes discourse in glial physiology and neurodegeneration research. His work contributes to UN Sustainable Development Goals for brain health research.

Aivi T. NguyenView profile

Assistant Clinical Professor

• Neurodegeneration
• Alzheimer's Disease
• Microglia
• +3 more

Aivi T. Nguyen, M.D., serves as a Clinical Assistant Professor in the Department of Laboratory Medicine and Pathology at Mayo Clinic Alix School of Medicine. As a board-certified neuropathologist and translational researcher, she spearheads investigations into neuroinflammation mechanisms in neurodegenerative diseases through the Alzheimer's Disease Research Center (ADRC) and Mayo Clinic Study of Aging (MCSA), integrating neuropathology with neuroimaging and biomarker analysis. Her educational trajectory includes: Post Doctoral Fellowship, Translational Neuropathology Research Laboratory (University of Pennsylvania, 2020) Neuropathology Fellowship (Hospital of the University of Pennsylvania, 2018) Anatomic Pathology Residency (Hospital of the University of Pennsylvania, 2016) M.D. (Jefferson Medical College, 2014) Research Fellowship (NIH Medical Research Scholars Program, 2013) B.S. in Cell and Molecular Biology, Genetics (University of Delaware, 2009) Dr. Nguyen's research centers on microglial heterogeneity in Alzheimer's disease, employing single-nuclei RNA sequencing and immunohistochemical validation to characterize distinct microglial subpopulations. She investigates how genetic risk variants (APOE E4, TREM2 R47H) modulate microglial responses to proteinopathies and explores microglia's role in cognitive resilience despite pathological burden. Her work bridges molecular mechanisms with clinical manifestations through multidisciplinary approaches. Analysis of her 2020-2025 publications reveals consistent focus on microglial biology across neurodegenerative conditions, with increasing emphasis on genetic determinants and translational applications. Recent work expands into TDP-43 proteinopathies and cerebral amyloid angiopathy while maintaining core investigation of microglial dynamics in Alzheimer's disease. Her accolades include: Two Diagnostic Slide Session Awards for Best Neurodegenerative Case (American Association of Neuropathology, 2021 & 2018) Neurodegenerative Disease Scholars Program Award and Robert Terry Award Honorable Mention (2020) Penn Cares Grant for 'Woodland Writers' Project (2015) Harold L. Stewart Prize in Pathology (2014) Dr. Nguyen actively shapes neuropathology standards through committee roles including the American Board of Pathology Test Development Advisory Committee and American Association of Neuropathologists Education Committee. Her research is supported by institutional resources within Mayo Clinic's ADRC infrastructure and collaborative multi-institutional grants. She operates within Mayo Clinic's integrated research ecosystem, contributing neuropathological expertise to the ADRC and MCSA teams while participating in national consortia studying neurodegenerative mechanisms. Her laboratory work focuses on human tissue analysis with emphasis on microglial transcriptomics and spatial pathology mapping.

Taras UsichenkoView profile

Professor

• Acupuncture
• Pain Management
• Anesthesia
• +3 more

Taras Usichenko is a Part-Time Professor in the Department of Anesthesia at McMaster University. His academic work focuses on integrating complementary medicine, particularly acupuncture and neurostimulation techniques, into clinical anesthesia and pain management. He has contributed extensively to research on auricular acupuncture, millimeter wave therapy, and their applications in surgical and postoperative care. Acupuncture in Perioperative Pain Control Neurostimulation for Anxiety and Stress Complementary and Alternative Medicine in Anesthesia Clinical Trials on Auricular Acupuncture Postoperative Cognitive Dysfunction His scholarly activity spans over two decades, with recent publications emphasizing systematic reviews, meta-analyses, and clinical applications in diverse areas such as pediatric pain, palliative care, and biomarker-driven delirium risk assessment. While no specific awards are listed, his work has been widely disseminated across international journals and conferences.

• Epilepsy
• mTOR Signaling
• Neurodevelopmental Disorders
• +5 more

Dr. Angelique Bordey is the Rothberg Professor of Neurosurgery and Vice Chair of Research at Yale School of Medicine. She holds secondary appointments in Cellular & Molecular Physiology and is affiliated with the Bordey Lab, Center for Brain & Mind Health, Interdepartmental Neuroscience Program, and Wu Tsai Institute. PhD in Neuroscience, Louis Pasteur University (1995) MS in Neurophysiology, University Louis Pasteur (1992) MS in Chemistry, National School of Engineering (1991) Her research focuses on mTOR signaling in neurological disorders like Tuberous Sclerosis Complex (TSC), autism, and epilepsy. Key projects include: (1) neural stem cell circuit formation in health and mTORopathies, (2) preventing brain malformations in TSC, and (3) molecular basis of autism in TSC using rodent models. She investigates synaptic dysfunction, cortical connectivity, and translational therapies targeting mTOR dysregulation. Recent publications highlight trends in mTOR-related epileptogenesis , Filamin A inhibition for seizure reduction, and 4E-BP1 expression to mitigate neuronal dysfunction. Awards include the Blavatnik Award (2022), Scientific Innovations Award (2022), NARSAD Distinguished Investigator Award (2015), and McKnight Neuroscience of Brain Disorder Award (2010). She has served on NIH study sections and secured federal/foundation grants for epilepsy research. Dr. Bordey leads the Bordey Lab, which explores neural stem cells, synaptic plasticity, and preclinical therapies for neurological disorders. The lab develops models for cortical malformations, autism, and glioma, with a focus on mTOR pathway targeting neurodevelopmental interventions translational neuroscience

Russell MortonView profile

Assistant Professor

• Neurophysiology
• Mild Traumatic Brain Injuries (mTBIs)
• Neurosciences
• +3 more

Russell Morton is a Tenure track Assistant Professor in the Department of Neurosciences at the University of New Mexico Health Sciences Center. He established expertise in neurophysiology and mild traumatic brain injuries (mTBIs) through postdoctoral research at the University of New Mexico and leadership roles in the Center for Brain Recovery and Repair (CBRR). B.A. in Psychology from University of Colorado at Boulder (2003) Ph.D. in Neuroscience from George Washington University (2011) Postdoctoral fellowship at University of New Mexico (2016) His research focuses on identifying spreading depolarizations (SDs) as critical mechanisms in concussion-like injuries, linking them to postinjury behavioral deficits, post-traumatic headaches, and impaired cognitive recovery. Using a closed skull injury model, his lab investigates SD propagation, cortical activity suppression, and blood flow dynamics in repeated mTBIs. This work aligns with CBRR's mission to bridge clinical and preclinical brain injury research. Russell Morton's publications highlight SDs' role in mild injuries and cognitive dysfunction. Key collaborations with Drs. Bill Shuttlworth (cellular SD mechanisms) and KC Brennan (headache/migraine research) enhance his studies. His work has been recognized through keynote invitations, grant leadership (DoD collaborative grant), and active participation in international spreading depolarization conferences. UNM Graduate Student Retreat Keynote Speaker (2014, 2017) General Public Poster Finalist, UNM Neuroscience Day (2014) First Place Oral Presentation, GWU Research Day (2008) As Preclinical Core Manager for CBRR, he developed the closed skull injury model and serves as a project lead. His lab collaborates with the New Mexico Spreading Depolarization Consortium (NMSDC) and international experts, maintaining weekly lab meetings with Drs. Shuttlworth and Brennan. He also co-teaches graduate courses in Neurosciences Journal Club, Neurophysiology, Methods in Cell Biology, and Undergraduate Pipeline Network.

James JakubowView profile

Lecturer

• Behavioral Pharmacology
• Mathematical Psychology
• Learning & Memory
• +3 more

James J. Jakubow is a University Instructor in the Department of Psychology at Florida Atlantic University's Charles E. Schmidt College of Science. With over 30 years of academic experience, he has taught 30,000+ students across courses in general psychology, behavioral pharmacology, learning & memory, and MCAT behavioral sciences review. His research spans behavioral neuroscience, mathematical psychology, and neuropharmacology. Ph.D. in Learning Processes (Graduate Center/CUNY, 2000) M.Phil. in Learning Processes (Graduate Center/CUNY, 1997) M.A. in Experimental Analysis of Behavior (Western Michigan University, 1988) His research focuses on mathematical models of associative learning, drug tolerance mechanisms, and theoretical approaches to learning & memory. Publications include textbook authorship and book reviews addressing behavioral neuroscience, cognitive dysfunction, and dynamical systems in psychology.

Allyson FriedmanView profile

Associate Professor

• Cellular Neurophysiology
• Neural Circuits
• Social Behavior
• +7 more

Dr. Allyson Friedman serves as an Associate Professor in the Department of Biological Sciences within Hunter College's School of Arts and Sciences at the City University of New York. She leads the Friedman Laboratory, which focuses on cellular neurophysiology and behavior research with significant contributions to understanding neural circuit mechanisms underlying social behaviors and affective disorders. Dr. Friedman's educational background includes: Postdoctoral Fellowship at Icahn School of Medicine at Mount Sinai Ph.D. from Mount Sinai School of Medicine of New York University B.A. from Barnard College, Columbia University Her research program investigates the neural circuits and neuroadaptations that mediate social behaviors, with particular emphasis on how affective disorders manifest as social dysfunction. The Friedman Laboratory explores how diverse coping strategies, sex hormones, and social support can induce changes in the underlying neural circuits guiding social behaviors. This research aims to identify beneficial and pathological neural adaptations that could lead to new therapeutic targets for mood and anxiety disorders. Dr. Friedman employs cutting-edge methodologies including cell-type/circuit specific in vitro electrophysiological recordings, viral-mediated gene transfer, and optogenetic manipulations in animal models to examine neural adaptations from the level of ion channels through to behavioral outcomes. Her publication record demonstrates consistent focus on stress response mechanisms, social behaviors, and mood disorders across multiple disciplines including neuroscience, psychiatry, pharmacology, and endocrinology. A recurring theme is the exploration of sex differences in neural responses to stress and their implications for affective disorders, with particular emphasis on the ventral tegmental area, amygdala, bed nucleus of stria terminalis, and related neural circuits. Her most recent work (2023) continues to advance understanding of how hormonal fluctuations influence neural excitability and social behavior under stress conditions. Dr. Friedman leads an active research laboratory at Hunter College with ongoing projects including 'Cell type specific mechanisms of stress adaptation in the bed nucleus of stria terminalis and the ventral tegmental area' and 'Neuropathophysiological Mechanisms of Premenstrual Dysphoric Disorder (PMDD).' Her laboratory appears to be well-integrated with the CUNY Neuroscience Collaborative and Hunter College's Biology department resources.

• Psychiatry
• Personality Disorders
• Social Cognition
• +5 more

Chiara De Panfilis is an Associate Professor of Psychiatry at the Department of Neuroscience, University of Parma (UNIPR), Italy, and Director of the Eating Disorders Program at Parma Local Health Agency. She specializes in personality disorders, particularly Borderline and Narcissistic Pathology, with a focus on social cognition, executive control, and psychosomatic comorbidities. Education: Medical degree (1997) and Specialist Certification in Psychiatry (2001), both cum laude at UNIPR. Research: Investigates neuroanatomical correlates of social dysfunction in BPD, effortful control's role in psychopathology, and personality interactions with medical conditions like obesity and eating disorders. Recent Trends: Her 2025-2024 work explores neurostimulation (tDCS) for emotional regulation in BPD and validation of motivation assessment tools for eating disorders. Awards: 2016 Research Award from the International Society for Transference-Focused Psychotherapy. Teaching: Educates across UNIPR's Medicine, Psychology, and Speech Therapy programs, with ongoing supervision of clinical trainees. Leadership: Co-Founder of the Personality Disorders Lab (PDLab) and active in regional/national eating disorder treatment planning.

Michael InouyeView profile

Professor

• Systems Genomics
• Cardiovascular Disease
• Population Health
• +3 more

Professor Michael Inouye is a leading systems genomics and population health researcher at the University of Cambridge (Department of Public Health and Primary Care) and Baker Heart & Diabetes Institute (Melbourne). His work bridges statistical genetics, computational biology, and clinical translation, with a focus on cardiovascular/respiratory diseases and sustainable research practices. Director of Research (Research Professor) since 2021 Honorary Professorial Fellow at University of Melbourne since 2021 Co-leader of Cambridge Baker Systems Genomics Initiative since 2017 Research Interests include: Polygenic risk score development and clinical implementation Multi-omic integration (genomics, proteomics, microbiomics) Host-microbiome interactions in disease Sustainable computational methodologies Cardiometabolic disease prevention Scientific Contributions show leadership in: Developing the Polygenic Score Catalog infrastructure Creating environmentally sustainable algorithmic frameworks Elucidating microbiome contributions to chronic diseases Advancing multi-modal risk prediction models Integrating genetic and metabolic pathway analysis Recent Publications demonstrate expertise across: Polygenic score optimization for blood traits and diabetes Microbiome-disease interaction networks Computational sustainability in biomedical research Cardiovascular risk stratification Multi-omic data harmonization Genetic determinants of molecular phenotypes

Lindsay ZillioxView profile

Associate Professor

• Peripheral Neuropathy
• Diabetic Neuropathy
• Clinical Neurophysiology
• +3 more

Lindsay Zilliox is an Associate Professor in the Department of Neurology at the University of Maryland School of Medicine , where she serves as the Division Director of the Neuromuscular Division . Her work bridges clinical neurophysiology, diabetes-related neurological disorders, and autonomic nervous system research.

Daniel Martin WattersonView profile

Professor

• Signal Transduction
• Neuroscience
• Pharmacology
• +6 more

Daniel Martin Watterson, PhD, is the John G. Searle Professor of Molecular Biology and Biochemistry at Northwestern University Feinberg School of Medicine, where he also serves as a Professor in the Department of Pharmacology. He focuses on eukaryotic signal transduction pathways and their roles in neurologic disorders, cancer, and inflammatory diseases. His research leverages genetic, informatic, and pharmacological approaches to develop novel therapeutic candidates. Current projects include optimizing small molecules for neurologic disorders, exploring preclinical treatments for depressive disorders, and validating therapies for gastrointestinal and pulmonary tissue barrier dysfunctions. Education: PhD in Biochemistry from Emory University (1975), Postgraduate Training in Bioorganic Chemistry at Duke University. Recent publications highlight his work on 5-HT2b inhibitors for Alzheimer's and neuropsychiatric disorders, PI3Kγ signaling in tumor inflammation, and anti-inflammatory drug candidates for neurodegenerative conditions. His research spans molecular biology, neuroscience, and translational medicine. Scientific Awards: National Academy of Inventors Fellow (2022) Melvin R. Goodes Prize for Alzheimer’s Drug Discovery Elan Award for Innovative Alzheimer’s Therapeutics With 39 patents to his name, Watterson's work bridges academic innovation and clinical application, particularly in neurodegenerative diseases and cancer biology. He actively collaborates with multidisciplinary teams and maintains leadership roles in major professional societies.

• Disability Studies
• Global Health
• Rehabilitation Sciences
• +7 more

Marco Tofani is a Tenure-Track Researcher at the Department of Life, Health, and Health Professions Sciences at Link Campus University in Rome. He specializes in Migration, Disability, and Global Health and holds a PhD in Infectious Diseases, Microbiology, and Public Health (2023) from Sapienza University of Rome. BSc in Neuro- and Psychomotor Therapy of Developmental Age (2009) BSc in Occupational Therapy (2014) Master's in Rehabilitation Sciences (2017) Specialization in Neurorehabilitation (Bobath concept, 2014) First Level Master's in Hand Rehabilitation (2015, University of Milan) His research focuses on disability validation studies , assistive technologies, and community-based rehabilitation frameworks. He collaborates with the Bambino Gesù Children's Hospital on pediatric dysphagia protocols and prosthetics, and serves as an international consultant for the World Health Organization in Ukraine. He co-founded the ROMA - Rehabilitation & Outcome Measures Assessment Association and leads the Disability and Migration Working Group at the Italian Society of Migration Medicine (since 2017). Recent publications include validation of clinical tools for pediatric dysphagia , prosthetic satisfaction, and global health equity, with a focus on cross-cultural adaptation and psychometric rigor. His work bridges clinical practice and policy for refugee populations. No scientific awards are explicitly listed in the provided text.